HIF-1α acts downstream of TNF-α to inhibit vasodilator- stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells

DNA and Cell Biology

Volumn 31, Issue 6, 2012, Pages 1078-1087

  Su, Ke ^a   Tian, Yihao ^a   Wang, Jing ^a   Shi, Wentao ^a   Luo, Daji ^a   Liu, Jian ^a   Tong, Zan ^a   Wu, Junzhu ^b   Zhang, Jingwei ^c   Wei, Lei ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ARTICLE; BREAST CANCER; CELL ADHESION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE REPRESSION; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICROFILAMENT PROTEINS; PHOSPHOPROTEINS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864049955     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1563     Document Type: Article

References (43)

1. Albina, J.E., Mastrofrancesco, B., Vessella, J.A., Louis, C.A., Henry, W.L., Jr., and Reichner, J.S. (2001). HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am J Physiol Cell Physiol 281, 1971-1977.
2. Anderson, G.M., Nakada, M.T., and DeWitte, M. (2004). Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 4, 314-320.
3. Barshishat, M., Ariel, A., Cahalon, L., Chowers, Y., Lider, O., and Schwartz, B. (2002). TNF-alpha and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells. Clin Exp Metastasis 19, 327-337.
4. Barzik, M., Kotova, T.I., Higgs, H.N., Hazelwood, L., Hanein, D., Gertler, F.B., and Schafer, D.A. (2005). Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J Biol Chem 280, 28653-28662.
5. Bear, J.E., Loureiro, J.J., Libova, I., Fassler, R., Wehland, J., and Gertler, F.B. (2000). Negative regulation of fibroblast motility by Ena/VASP proteins. Cell 101, 717-728.
6. Brindle, N.P., Holt, M.R., Davies, J.E., Price, C.J., and Critchley, D. R. (1996). The focal-adhesion vasodilator-stimulated phosphoprotein (VASP) binds to the proline-rich domain in vinculin. Biochem J 318, 753-757.
7. Chen, K.F., Lai, Y.Y., Sun, H.S., and Tsai, S.J. (2005). Transcriptional repression of human cad gene by hypoxia inducible factor-1alpha. Nucleic Acids Res 33, 5190-5198.
8. Chen, M., and Geng, J.G. (2006). P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp (Warsz) 54, 75-84.
9. Dertsiz, L., Ozbilim, G., Kayisli, Y., Gokhan, G.A., Demircan, A., and Kayisli, U.A. (2005). Differential expression of VASP in normal lung tissue and lung adenocarcinomas. Thorax 60, 576-581.
10. Fajardo, L.F., Kwan, H.H., Kowalski, J., Prionas, S.D., and Allison, A.C. (1992). Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol 140, 539-544.
11. Galler, A.B., Garcia Arguinzonis, M.I., Baumgartner, W., Kuhn, M., Smolenski, A., Simm, A., and Reinhard, M. (2006). VASPdependent regulation of actin cytoskeleton rigidity, cell adhesion, and detachment. Histochem Cell Biol 125, 457-474.
12. Han, Y.P., Nien, Y.D., and Garner, W.L. (2002). Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by downregulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase. J Biol Chem 277, 27319-27327.
13. Hellwig-Burgel, T., Rutkowski, K., Metzen, E., Fandrey, J., and Jelkmann, W. (1999). Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94, 1561-1567.
14. Huttenlocher, A., Palecek, S.P., Lu, Q., Zhang, W., Mellgren, R.L., Lauffenburger, D.A., Ginsberg, M.H., and Horwitz, A.F. (1997). Regulation of cell migration by the calcium-dependent protease calpain. J Biol Chem 272, 32719-32722.
15. Huttenlocher, A., Sandborg, R.R., and Horwitz, A.F. (1995). Adhesion in cell migration. Curr Opin Cell Biol 7, 697-706.
16. Henes, J., Schmit, M.A., Morote-Garcia, J.C., Mirakaj, V., Kohler, D., Glover, L., Eldh, T., Walter, U., Karhausen, J., Colgan, S.P., and Rosenberger, P. (2009). Inflammation-associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury. FASEB J 23, 4244-4255.
17. Katerinaki, E., Evans, G.S., Lorigan, P.C., and MacNeil, S. (2003). TNF-alpha increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes. Br J Cancer 89, 1123-1129.
18. Katerinaki, E., Haycock, J.W., Lalla, R., Carlson, K.E., Yang, Y., Hill, R.P., Lorigan, P.C., and MacNeil, S. (2006). Sodium salicylate inhibits TNF-alpha-induced NF-kappaB activation, cell migration, invasion and ICAM-1 expression in human melanoma cells. Melanoma Res 16, 11-22.
19. Kato, R., Ishikawa, T., Kamiya, S., Oguma, F., Ueki, M., Goto, S., Nakamura, H., Katayama, T., and Fukai, F. (2002). A new type of antimetastatic peptide derived from fibronectin. Clin Cancer Res 8, 2455-2462.
20. Khatib, A.M., Kontogiannea, M., Fallavollita, L., Jamison, B., Meterissian, S., and Brodt, P. (1999). Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 59, 1356-1361.
21. Krause, M., Dent, E.W., Bear, J.E., Loureiro, J.J., and Gertler, F.B. (2003). Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 19, 541-564.
22. Le, C.C., and Carlier, M.F. (2008). Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 88, 489-513.
23. Liang, Z., Wu, T., Lou, H., Yu, X., Taichman, R.S., Lau, S.K., Nie, S., Umbreit, J., and Shim, H. (2004). Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64, 4302-4308.
24. Liotta, L.A., Wewer, U., Rao, N.C., Schiffmann, E., Stracke, M., Guirguis, R., Thorgeirsson, U., Muschel, R., and Sobel, M. (1987). Biochemical mechanisms of tumor invasion and metastasis. Anticancer Drug Des 2, 195-202.
25. Liu, K., Li, L., Nisson, P.E., Gruber, C., Jessee, J., and Cohen, S.N. 1999. Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein. Mol Cell Biol 19, 3696-3703.
26. Mareel, M., and Leroy, A. (2003). Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83, 337-376.
27. Mochizuki, Y., Nakanishi, H., Kodera, Y., Ito, S., Yamamura, Y., Kato, T., Hibi, K., Akiyama, S., Nakao, A., and Tatematsu, M. (2004). TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis 21, 39-47.
28. Peng, X.C., Zhang, J.W., and Wei, L. (2009). Study of expression of VASP in gastric Carcinoma. J Yangtze University (Natural Science Edition) 6, 20-22.
29. Prevost-Blondel, A., Roth, E., Rosenthal, F.M., and Pircher, H. (2000). Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo. J Immunol 164, 3645-3651.
30. Reinhard, M., Jouvenal, K., Tripier, D., and Walter, U. (1995). Identification, purification, and characterization of a zyxinrelated protein that binds the focal adhesion and microfilament protein VASP (vasodilator-stimulated phosphoprotein). Proc Natl Acad Sci 92, 7956-7960.
31. Rosenberger, P., Khoury, J., Kong, T., Weissmuller, T., Robinson, A.M., and Colgan, S.P. (2007). Identification of vasodilatorstimulated phosphoprotein (VASP) as an HIF-regulated tissue permeability factor during hypoxia. FASEB J 21, 2613-2621.
32. Schirenbeck, A., Arasada, R., Bretschneider, T., Stradal, T.E., Schleicher, M., and Faix, J. (2006). The bundling activity of vasodilator-stimulated phosphoprotein is required for filopodium formation. Proc Natl Acad Sci 103, 7694-7699.
33. Sechi, A.S., and Wehland, J. (2004). ENA/VASP proteins: multifunctional regulators of actin cytoskeleton dynamics. Front Biosci 9, 1294-1310.
34. Semenza, G.L. (2002). HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8, 62-67.
35. Talks, K.L., Turley, H., Gatter, K.C., Maxwell, P.H., Pugh, C.W., Ratcliffe, P.J., and Harris, A.L. (2000). The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumorassociated macrophages. Am J Pathol 157, 411-421.
36. van Diest, P.J., Vleugel, M.M., and van der Wall, E. (2005). Expression of HIF-1 alpha in human tumours. J Clin Pathol 58, 335-336.
37. Wielockx, B., Lannoy, K., Shapiro, S.D., Itoh, T., Itohara, S., Vandekerckhove, J., and Libert, C. (2001). Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat Med 7, 1202-1208.
38. Wilt, S.G., Milward, E., Zhou, J.M., Nagasato, K., Patton, H., Rusten, R., Griffin, D.E., OConnor, M., and Dubois-Dalcq, M. (1995). In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. Ann Neurol 37, 381-394.
39. Witte, M., Shealy, D., Nakada, M., and Anderson, G. (2007). Tumor necrosis factor and cancer. In Cytokines in the Genesis and Treatment of Cancer. M.A. Caligiuri, and M.T Lotze, eds. (Humana Press Inc, NJ), pp. 71-89.
40. Yin, Y., Chen, X., and Shu, Y. (2009). Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells. Biomed Pharmacother 63, 421-428.
41. Zhang, Y., Tu, Y., Gkretsi, V., and Wu, C. (2006). Migfilin interacts with vasodilator-stimulated phosphoprotein (VASP) and regulates VASP localization to cell-matrix adhesions and migration. J Biol Chem 281, 12397-12407.
42. Zhong, H., De Marzo, A.M., Laughner, E., Lim, M., Hilton, D.A., Zagzag, D., Buechler, P., Isaacs, W.B., Semenza, G.L., and Simons, J.W. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59, 5830-5835.
43. Zhu, N., Lalla, R., Eves, P., Brown, T.L., King, A., Kemp, E.H., Haycock, J.W., and MacNeil, S. (2004). Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone. Br J Cancer 90, 1457-1463.